| Autor: |
Dahivelkar, Sachinkumar, Mali, Shrikant B., Mahajan, Aarti, Prakash, Nilima |
| Předmět: |
|
| Zdroj: |
Oral Surgery (1752-2471); May2024, Vol. 17 Issue 2, p161-169, 9p |
| Abstrakt: |
Introduction: Ameloblastoma is one of the most frequent benign odontogenic tumours of the jaw, accounting for approximately 10% of all tumours in the mandible and maxilla. It is a slow‐growing, locally invasive tumour that causes painless swelling of the jaw or maxilla. Diagnosis: Ameloblastoma is diagnosed through computerised tomography imaging and a biopsy. A biopsy can help distinguish ameloblastoma from other cancers, such as ossifying fibroma, osteomyelitis, giant cell tumour, cystic fibrous dysplasia, myeloma, and sarcoma. Treatment: Ameloblastoma is best treated with vigorous en bloc excision and concomitant repair. Ameloblastoma therapy has long been plagued by high recurrence rates and extensive tissue abnormalities. Recent molecular findings strongly imply that ameloblastoma patients may benefit from targeted treatment. We offer a case report of unicystic ameloblastoma with a step‐by‐step customised therapeutic plan that prioritises patients' desire. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Plný text